<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Cytomegalovirus (CMV) | UTI PathoDB</title>
  <script src="https://cdn.tailwindcss.com"></script>
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
</head>
<body class="bg-gray-50 text-gray-800">
  <!-- Navbar -->
  <nav class="bg-blue-900 text-white p-4">
    <div class="container mx-auto flex justify-between items-center">
      <a href="../index.html" class="text-xl font-bold text-teal-300 flex items-center">
        <i class="fas fa-bacteria mr-2"></i> UTI PathoDB
      </a>
      <ul class="flex space-x-6">
        <li><a href="../index.html" class="hover:text-teal-300">Home</a></li>
        <li><a href="../uti-info.html" class="hover:text-teal-300">UTI Info</a></li>
      </ul>
    </div>
  </nav>

  <!-- Header -->
  <header class="bg-teal-600 text-white py-12 text-center">
    <h1 class="text-4xl font-bold">Cytomegalovirus (CMV)</h1>
    <p class="text-lg opacity-90">A viral pathogen associated with UTIs in immunocompromised individuals</p>
  </header>

  <!-- Main Content -->
  <main class="py-10 px-6 max-w-6xl mx-auto space-y-12">
    <!-- Overview -->
    <section>
      <h2 class="text-2xl font-semibold text-blue-800 mb-4">
        <i class="fas fa-info-circle mr-2 text-teal-500"></i> Overview
      </h2>
      <p>
        Cytomegalovirus (CMV) is a DNA virus of the Herpesviridae family. While asymptomatic in healthy individuals, CMV can cause significant disease in immunocompromised patients. In the urinary tract, CMV may lead to hemorrhagic cystitis or viral shedding in urine post-transplant or during congenital infection.
      </p>
    </section>

    <!-- Molecular Markers -->
    <section>
      <h2 class="text-2xl font-semibold text-blue-800 mb-4">
        <i class="fas fa-dna mr-2 text-teal-500"></i> Molecular Markers
      </h2>
      <ul class="list-disc pl-5 space-y-1">
        <li>dsDNA genome ~235 kb with >200 genes</li>
        <li>Immediate-early genes (IE1/IE2) for viral replication and latency</li>
        <li>pp65 antigen used in diagnostic assays</li>
        <li>UL97 gene mutations linked to antiviral resistance</li>
      </ul>
    </section>

    <!-- Immune Response -->
    <section>
      <h2 class="text-2xl font-semibold text-blue-800 mb-4">
        <i class="fas fa-shield-virus mr-2 text-teal-500"></i> Immune Response
      </h2>
      <p>
        CMV activates both innate and adaptive immunity. CD8+ T-cells and NK cells play key roles in viral clearance. In immunosuppressed patients, the virus evades immunity via downregulating MHC I and expressing viral cytokine homologs.
      </p>
    </section>

    <!-- Epidemiology -->
    <section>
      <h2 class="text-2xl font-semibold text-blue-800 mb-4">
        <i class="fas fa-chart-line mr-2 text-teal-500"></i> Epidemiology
      </h2>
      <ul class="list-disc pl-5 space-y-1">
        <li>CMV seroprevalence >60% globally</li>
        <li>Associated with congenital infections and post-transplant complications</li>
        <li>Urinary tract involvement noted in neonatal and transplant cases</li>
      </ul>
    </section>

    <!-- Treatment -->
    <section>
      <h2 class="text-2xl font-semibold text-blue-800 mb-4">
        <i class="fas fa-pills mr-2 text-teal-500"></i> Treatment
      </h2>
      <ul class="list-disc pl-5 space-y-1">
        <li><strong>Antivirals:</strong> Ganciclovir (IV), Valganciclovir (oral)</li>
        <li><strong>Resistant strains:</strong> Foscarnet or Cidofovir</li>
        <li>Preemptive therapy based on viral load monitoring post-transplant</li>
        <li>CMV vaccines are under investigation but not yet approved</li>
      </ul>
    </section>

    <!-- References -->
    <section>
      <h2 class="text-2xl font-semibold text-blue-800 mb-4">
        <i class="fas fa-book mr-2 text-teal-500"></i> References
      </h2>
      <ol class="list-decimal pl-5 space-y-1 text-gray-700">
        <li>Boeckh M, Geballe AP. Cytomegalovirus: pathogen, paradigm, and puzzle. <strong>J Clin Invest</strong>. 2011;121(5):1673â€“80.</li>
        <li>Razonable RR. Cytomegalovirus infection after transplantation. <strong>World J Gastroenterol</strong>. 2008;14(31):4849.</li>
        <li>CDC. Cytomegalovirus (CMV) and Congenital CMV Infection. www.cdc.gov</li>
      </ol>
    </section>
  </main>

  <!-- Footer -->
  <footer class="bg-blue-900 text-white text-center py-6">
    <p>&copy; 2025 UTI PathoDB. All rights reserved.</p>
  </footer>
</body>
</html>
